r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

CV

Coelho Rogerio Vivaldi

Insider · Director · CRNX

Coelho Rogerio Vivaldi files insider transactions with the SEC as a director of Crinetics Pharmaceuticals (CRNX). We hold 2 disclosed purchases and sales filed since 9 July 2014, 1 of them in the last 90 days.

  • Files forCRNX
  • Disclosed buys and sells2 in all, 1 in the last 90 days
  • Last disclosure1 September 2026

Positions held

6 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 January 2022 — 1 September 2026Director · Crinetics Pharmaceuticals (CRNX)25 Form 4 lines · source: SEC Form 4
  • Filed 3 June 2024 — 6 March 2026Director · Viatris (VTRS)16 Form 4 lines · source: SEC Form 4
  • Filed 8 December 2020 — 11 August 2023President and CEO · Sigilon Therapeutics (SGTX)11 Form 4 lines · source: SEC Form 4
  • Filed 14 February 2017 — 8 March 2018EVP, Chief Global Therapeutics · Bioverativ (BIVV)14 Form 4 lines · source: SEC Form 4
  • Filed 4 February 2015 — 15 July 2016Chief Commercial Officer · Spark Therapeutics (ONCE)30 Form 4 lines · source: SEC Form 4
  • Filed 30 June 2014 — 1 July 2014President and CEO · Minerva Neurosciences (NERV)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

98 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.